Back to Search
Start Over
Treating in the dark: unanswered questions on costs and benefits of late line therapy for metastatic breast cancer
- Source :
- Cancer investigation. 27(1)
- Publication Year :
- 2009
-
Abstract
- Breast cancer remains the most common malignancy diagnosed among women with 182,460 cases estimated in the United States during the year 2008. Although the incidence of breast cancer appears to be ...
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Chemotherapy
Time Factors
Cost–benefit analysis
business.industry
Incidence (epidemiology)
medicine.medical_treatment
Cost-Benefit Analysis
Antineoplastic Agents
Breast Neoplasms
General Medicine
Malignancy
medicine.disease
Metastatic breast cancer
Breast cancer
Models, Economic
Internal medicine
medicine
Humans
Female
skin and connective tissue diseases
business
Subjects
Details
- ISSN :
- 15324192
- Volume :
- 27
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Cancer investigation
- Accession number :
- edsair.doi.dedup.....c35805a86b787dd369dd9c3d21c14053